i hear people talking about other public offerings. As biotechs become bigger, they never only have 12 million shares outstanding. would they dare have a second offering so soon after the last one?
im in at 2.82 (before offering) and then 2.09 and even at that low price it is hard watching it edge lower and lower. But ive read a few books and become a little wiser. A watched stock never boils.
if you didn't buy on margin then just relax. Only thing worrying me now is efficacy. But other than that holding till teens.
well i cant see them making money. But possibly not losing as much as we thought they would and also possibly partnership annoucnement? i geuss those would be the only real catalysts. Kinda liek when green mountain coffee jumped 40% when they announced partnership with cocal cola and that cocal cola owned 10% of them
true direction soon